Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.38 - $22.5 $6,270 - $371,250
-16,500 Reduced 58.51%
11,700 $4,000
Q3 2022

Nov 14, 2022

SELL
$0.73 - $23.4 $31,682 - $1.02 Million
-43,400 Reduced 60.61%
28,200 $20,000
Q2 2022

Aug 15, 2022

SELL
$0.66 - $1.81 $27,654 - $75,839
-41,900 Reduced 36.92%
71,600 $58,000
Q1 2022

May 16, 2022

BUY
$1.27 - $2.47 $91,821 - $178,581
72,300 Added 175.49%
113,500 $188,000
Q4 2021

Feb 14, 2022

SELL
$2.21 - $3.22 $948,532 - $1.38 Million
-429,200 Reduced 91.24%
41,200 $96,000
Q3 2021

Nov 15, 2021

BUY
$2.8 - $3.72 $1.1 Million - $1.47 Million
394,400 Added 518.95%
470,400 $1.46 Million
Q2 2021

Aug 11, 2021

SELL
$2.61 - $4.17 $20,619 - $32,943
-7,900 Reduced 9.42%
76,000 $255,000
Q1 2021

May 17, 2021

BUY
$2.91 - $4.32 $75,660 - $112,320
26,000 Added 44.91%
83,900 $261,000
Q4 2020

Feb 16, 2021

SELL
$2.15 - $3.5 $583,080 - $949,200
-271,200 Reduced 82.41%
57,900 $159,000
Q3 2020

Nov 16, 2020

SELL
$2.77 - $6.17 $190,299 - $423,879
-68,700 Reduced 17.27%
329,100 $941,000
Q2 2020

Aug 14, 2020

BUY
$0.87 - $3.13 $336,516 - $1.21 Million
386,800 Added 3516.36%
397,800 $1.23 Million
Q1 2018

May 15, 2018

BUY
$3.5 - $4.47 $38,500 - $49,170
11,000 New
11,000 $39,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.